Preclinical Absorption, Distribution, Metabolism, and Excretion of an Oral Amide Prodrug of Gemcitabine Designed to Deliver Prolonged Systemic Exposure-Reference-Cited by-同舟云学术

Preclinical Absorption, Distribution, Metabolism, and Excretion of an Oral Amide Prodrug of Gemcitabine Designed to Deliver Prolonged Systemic Exposure

Published:2013-05-08 Issue:4 Volume:5 Page:261-276
ISSN:1999-4923
Container-title:Pharmaceutics
language:en
Short-container-title:Pharmaceutics

Author:

Wickremsinhe Enaksha,Bao Jingqi,Smith Richard,Burton Richard,Dow Shannon,Perkins Everett

Publisher

MDPI AG

Subject

Pharmaceutical Science

Link

http://www.mdpi.com/1999-4923/5/2/261/pdf

Reference36 articles.

1. Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: A randomized trial;Burris;J. Clin. Oncol.,1997

2. Gemcitabine in the treatment of metastatic pancreatic cancer

3. Role of gemcitabine in ovarian cancer treatment

4. The role of gemcitabine in first-line treatment of advanced ovarian carcinoma;Thigpen;Semin. Oncol.,2006

5. Gemcitabine and radiation therapy in non-small cell lung cancer: state of the art

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prodrugs as empowering tools in drug discovery and development: recent strategic applications of drug delivery solutions to mitigate challenges associated with lead compounds and drug candidates;Chemical Society Reviews;2024

2. Synthesis and anticancer evaluation of acetylated-lysine conjugated gemcitabine prodrugs;RSC Medicinal Chemistry;2023

3. Permeability of Gemcitabine and PBPK Modeling to Assess Oral Administration;Current Issues in Molecular Biology;2021-12-07

4. The Current Treatment Paradigm for Pancreatic Ductal Adenocarcinoma and Barriers to Therapeutic Efficacy;Frontiers in Oncology;2021-07-15

5. Design, synthesis, and evaluation of liver-specific gemcitabine prodrugs for potential treatment of hepatitis C virus infection and hepatocellular carcinoma;European Journal of Medicinal Chemistry;2021-03